January 30 - February 3, 2027
San Diego, CA, USA
January 30 - February 3, 2027
San Diego, CA, USA

Announcing the SLAS2027 Innovation AveNEW companies!
Addimus Bio GmbH (Germany)
Develops automated liquid handling solutions for 3D cell culture and sample preparation
Kiosk: 1456-A
Autology (United States)
The inversion of biological measurement: a wireless instrument inside the standard microplate, streaming real-time telemetry from every well
Kiosk: 1456-C
Apricell Biotechnology Inc. (Canada)
A modular organoid-on-a-plate technology platform for human-relevant therapeutic screening and preclinical decision-making
Kiosk: 1456-B
Tactus AI, Inc. (United States)
Elsie: A humanoid robot and AI lab orchestrator for autonomous laboratory workflows
Kiosk: 1456-N
Sarpeda (United States)
Develops AI software that improves fluorescence microscopy signal quality and marker detection.
Kiosk: 1456-M
Cytely AB (Sweden)
Provides automated image analysis software for reproducible drug discovery by standardizing biological measurements.
Kiosk: 1456-G
Reflex Bio (United States)
ReflexBio is an execution layer that turns plain-language scientific intent into reliable physical execution on the instruments a lab already owns.
Kiosk: 1456-L
Orbits Oncology (United States)
Develops AI-powered image analysis for organoid drug screening and precision oncology research.
Kiosk: 1456-K
Blotting Innovations (United States)
G-Blot: a 96-well polyacrylamide gel for electrophoresis and Western Blotting
Kiosk: 1456-D
Exciting Instruments (United Kingdom)
Confocal fluorescence spectroscopy for solution-based binding and complex formation screening
Kiosk: 1456-H
Coherence Biotech Co. Ltd. (United States/Taiwan)
Develops benchtop automation for cell-based assays, integrating culture, dosing and imaging.
Kiosk: 1456-F
Cambrian Bioworks (India)
Develops laboratory automation platforms for nucleic acid extraction and NGS library preparation.
Kiosk: 1456-E
openUC2 GmbH (Germany)
A fully modular and open-source microscopy platform to serve high-throughput lab automation applications
Kiosk: 1456-J
TissueLabs (Switzerland)
Integrated biofabrication platform for human tissue models
Kiosk: 1456-O
Media City Scientific (Austrailia)
Serum free and coating free cell culture platform
Kiosk: 1456-I
For more information about the goals of Innovation AveNEW, download the brochure or listen to the New Matter podcasts linked below.
Download the Innovation AveNEW Brochure
Want to learn more about how Innovation AveNEW can launch your startup into the stratosphere? Read the latest from “Cruising the AveNEW: How SLAS Boosts Startup Visibility in Life Sciences.”
Interested companies must align in some fashion with the area of life sciences and technology and while not required, an established relationship with a university, bioscience incubator or research institution is preferable. The company’s products and/or services must be available for sale/distribution within the year of their conference participation.
To ensure that participating startups are well-positioned for the Innovation AveNEW program, the following eligibility criteria will be considered:
Companies that have previously exhibited on Innovation AveNEW are not eligible to apply again. Innovation AveNEW companies are not permitted to purchase a booth on the exhibit floor.
By adhering to these criteria, Innovation AveNEW aims to attract startups that are mature enough to engage meaningfully with potential clients and investors, yet still young and agile enough to benefit from the program's offerings. If your company is more mature, we suggest applying for SLAS's New Product Award, which will support your mission and marketing strategy.
All applications are reviewed by the Innovation AveNEW Review Panel, who will evaluate applications for technical merit and commercial feasibility as well as other criteria, inclusive of, but not limited to:
SLAS reserves the right to select and deselect any company at any given time. All decisions are final. Companies selected for participation in Innovation AveNEW must agree to and adhere to the rules and regulations for participation.
SLAS is dedicated to advancing life sciences discovery and technology and connecting its users to each other. To fulfill that mission, companies selected to participate in Innovation AveNEW receive at no cost:
SLAS2027 Innovation AveNEW Application deadline: Monday, September 14
Ignite Award Opt-In (open to accepted Innovation AveNEW companies) deadline: Monday, November 9.
Need more information? Contact Stephanie Salerno, Program Manager.